HutchMED (China) LIMITED Operating Cash Flow
HutchMED (China) LIMITED (HMDCF) reported Operating Cash Flow of -$64.66 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-03-05
- HutchMED (China) LIMITED net cash provided by (used in) operating activities for the quarter ending 2019-12-31 was -$17.39M.
- HutchMED (China) LIMITED net cash provided by (used in) operating activities for the quarter ending 2019-09-30 was -$33.48M.
- HutchMED (China) LIMITED net cash provided by (used in) operating activities for the quarter ending 2019-06-30 was -$1.12M, a 109.16% decline year-over-year.
- HutchMED (China) LIMITED net cash provided by (used in) operating activities for the quarter ending 2019-03-31 was -$28.92M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$64.66M 20-F · filed 2026-03-05 | |||
| 2025-06-30 | -$72.89M 6-K · filed 2025-08-07 | |||
| 2024-12-31 | $497.00K 20-F · filed 2026-03-05 | |||
| 2024-06-30 | -$39.83M 6-K · filed 2025-08-07 | |||
| 2023-12-31 | $219.26M 20-F · filed 2026-03-05 | |||
| 2023-06-30 | $226.40M 6-K · filed 2024-07-31 | |||
| 2022-12-31 | -$268.60M 20-F · filed 2025-03-19 | |||
| 2022-06-30 | -$89.86M 6-K · filed 2023-07-31 | |||
| 2021-12-31 | -$204.22M 20-F · filed 2024-02-28 | |||
| 2021-06-30 | -$71.32M 6-K · filed 2022-08-01 | |||
| 2020-12-31 | -$62.07M 20-F · filed 2023-02-28 | |||
| 2020-06-30 | -$28.38M 6-K · filed 2021-07-28 | |||
| 2019-12-31 | -$17.39M derived: 20-F 12 month − 6-K 9 month · filed 2022-03-03 | -$50.87M derived: sum of 2 quarters · filed 2022-03-03 | -$51.99M derived: sum of 3 quarters · filed 2022-03-03 | -$80.91M 20-F · filed 2022-03-03 |
| 2019-09-30 | -$33.48M derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | -$34.60M derived: sum of 2 quarters · filed 2020-07-30 | -$63.53M 6-K · filed 2020-01-21 | -$77.46M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-06-30 | -$1.12M derived: 6-K 6 month − 6-K 3 month · filed 2020-07-30 | -$30.05M 6-K · filed 2020-07-30 | -$43.98M derived: sum of 3 quarters · filed 2021-03-04 | -$44.30M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-03-31 | -$28.92M 6-K · filed 2019-06-06 | -$42.86M derived: sum of 2 quarters · filed 2021-03-04 | -$43.17M derived: sum of 3 quarters · filed 2021-03-04 | -$30.93M derived: sum of 4 quarters · filed 2021-03-04 |
| 2018-12-31 | -$13.94M derived: 20-F 12 month − 6-K 9 month · filed 2021-03-04 | -$14.25M derived: sum of 2 quarters · filed 2021-03-04 | -$2.01M derived: sum of 3 quarters · filed 2021-03-04 | -$32.85M 20-F · filed 2021-03-04 |
| 2018-09-30 | -$315.00K derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | $11.93M derived: sum of 2 quarters · filed 2020-01-21 | -$18.91M 6-K · filed 2020-01-21 | |
| 2018-06-30 | $12.24M derived: 6-K 6 month − 6-K 3 month · filed 2019-07-30 | -$18.60M 6-K · filed 2019-07-30 | ||
| 2018-03-31 | -$30.84M 6-K · filed 2019-06-06 | |||
| 2017-12-31 | -$8.94M 20-F · filed 2020-03-03 | |||
| 2017-06-30 | $19.42M 6-K · filed 2018-07-27 | |||
| 2016-12-31 | -$9.57M 20-F · filed 2019-03-11 | |||
| 2016-06-30 | $9.05M 6-K · filed 2017-07-31 | |||
| 2015-12-31 | -$9.38M 20-F · filed 2018-03-12 | |||
| 2014-12-31 | $8.36M 20-F · filed 2017-03-13 |